Ireland
--:--IST
Starting soon Not applicable

Comparison of ESP Block and STAP Plane Block

NCT06663449 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-12-15
Last updated
2024-12-05

Condition(s) studied

Postoperative Pain

Investigational drug(s) / intervention(s)

subcostal transversus abdominis plane blockerector spinae plane block

subcostal transversus abdominis plane block: subcostal transversus abdominis plane block will be performed using 20 mL of 0.25 bupivacaine

erector spinae plane block: erector spinae plane block will be performed using 20 mL of 0.25 bupivacaine

Study summary

In order to effectively manage postoperative analgesia in patients planned to undergo elective laparoscopic cholecystectomy, patients will be divided into 2 (two) groups and informed consent forms will be obtained after the necessary information is provided so that both groups can be included in the study. In the group planned to undergo erector spinae plane block, erector spinae plane block will be performed after monitoring and sedation in the operating room block unit before being taken to the surgical table preoperatively and postoperative PCA analgesia will be applied. In patients who will undergo subcostal transversus abdominis plane block, subcostal tap block will be performed after monitoring and sedation in the operating room block unit before being taken to the surgical table preoperatively and postoperative PCA analgesia will be applied. The patients' perioperative pain will be monitored with NOL (nociception level) monitor. Remifentanil dose will be adjusted to keep the NOL level between 10 and 25. After the patients are followed up for 24 hours postoperatively, their additional analgesia needs and amounts during this process will be compared. In this way, it is aimed to show that the analgesic method can be used effectively in the follow-up of pain management by comparing the Erector Spina Plane block and the Subcostal Transversus Abdominis Plane block as an effective analgesic application in laparoscopic cholecystectomy operations.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Patients who will undergo laparoscopic cholecystectomy: * 18-75 years old * ASA I-II-III patients Exclusion Criteria: * Use of anticoagulant drugs * Known allergy to drugs to be used * Infection in the area where the block will be performed * Patient's reluctance

Primary outcome measure(s)

  • NRS Scores — 1 hours after surgery(T1), 3 hours after surgery (T2), 6 hours after surgery (T3), 12 hours after surgery (T4) and 24 hours after surgery(T5)
    NRS scores of the patients after the surgery (0=no pain, 10=worst pain imaginable)
  • Morphine consumption — 1 hours after surgery(T1), 3 hours after surgery (T2), 6 hours after surgery (T3), 12 hours after surgery (T4) and 24 hours after surgery(T5)
    Amount of morphine consumption (mg)

Trial sites (1)

FacilityCityRegionStatus
Kocaeli University Kocaeli Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06663449 on ClinicalTrials.gov ↗ ← All trials in Turkey